Drug-eluting balloon tech attracts $16M round

Surgical balloons could become good drug-delivery tools. CV Ingenuity is developing a system that could bring a new twist to the treatment of peripheral artery disease, with a drug-eluting balloon system that delivers anti-clotting drugs during procedures to open narrowed blood vessels. With its novel treatment approach, the Palo Alto, CA-based firm has raised $16 million in a Series B round of financing led by new backer New Enterprise Associates. The round also attracted funding from previous investors BioStar Ventures, Synergy Ventures and Western Technology. Article

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.